• KX2-391 Dihydrochloride Suppresses HBV Transcription via Tub

  2026-04-28

  This study identifies KX2-391 dihydrochloride (Tirbanibulin dihydrochloride) as a potent inhibitor of hepatitis B virus (HBV) transcription, acting through disruption of tubulin polymerization rather than Src kinase inhibition. The findings provide a mechanistically distinct approach to HBV suppression, with implications for developing novel antiviral strategies targeting host cell processes.

• Cy3 TSA Fluorescence System Kit: Precision Signal Amplificat

  2026-04-28

  The Cy3 TSA Fluorescence System Kit from APExBIO offers unparalleled sensitivity for detecting low-abundance biomolecules across IHC, ICC, and ISH workflows. Its tyramide-based amplification unlocks advanced spatial and quantitative insights unattainable by conventional fluorescence methods.

• Iron Stress Reprograms Enterocyte Metabolism and Inflammatio

  2026-04-27

  Navazesh and Ji's 2025 study demonstrates that both iron deficiency and iron excess profoundly alter enterocyte metabolism and inflammatory signaling in IPEC-J2 cells. By integrating untargeted metabolomics and gene expression analyses, the paper reveals distinct metabolic vulnerabilities and adaptive responses, offering new avenues for research into intestinal health and iron-dependent cellular pathways.

• H 89 2HCl: Precision cAMP/PKA Pathway Inhibition in Cell Mod

  2026-04-27

  H 89 2HCl enables highly selective, quantitative inhibition of protein kinase A, empowering dissection of cAMP/PKA signaling in neurobiology and bone research. Explore advanced protocols, troubleshooting strategies, and practical insights derived from cutting-edge studies.

• Redefining Sensitivity: TCEP Hydrochloride in Translational

  2026-04-26

  Explore how tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride) is transforming the frontier of protein analysis and diagnostic assay sensitivity. This thought-leadership article dissects mechanistic advances, highlights strategic recommendations for translational researchers, and positions APExBIO’s TCEP hydrochloride as a linchpin for next-generation, high-affinity ‘capture-and-release’ workflows in lateral flow and advanced biochemical assays.

• Mitomycin C: Antitumor Antibiotic for Advanced Cancer Resear

  2026-04-25

  Mitomycin C, a benchmark antitumor antibiotic, offers robust DNA replication inhibition and p53-independent apoptosis potentiation for apoptosis signaling and colon cancer models. This article delivers workflow-optimized protocols, troubleshooting strategies, and actionable insights drawn from recent innovations, ensuring reproducible and high-impact results in cancer research.

• Merimepodib (VX-497): Precision Targeting of Nucleotide Meta

  2026-04-24

  Explore how Merimepodib (VX-497) enables precise, selective IMPDH inhibition for advanced oncology, immunology, and virology applications. This article reveals new metabolic insights and protocol guidance grounded in recent virology research.

• Bafilomycin A1: Mechanistic Leverage in Lysosomal and Mitoph

  2026-04-24

  Explore how APExBIO’s Bafilomycin A1 is reshaping the translational landscape of lysosomal function, mitophagy, and odontoblastic differentiation. Integrating new mechanistic insights from stem cell research with actionable experimental guidance, this thought-leadership piece advances the conversation beyond standard protocols and product pages.

• Amyloid Beta-peptide (25-35): Precision Tool for Neurotoxici

  2026-04-23

  Amyloid Beta-peptide (25-35) (Aβ25-35) is a validated neurotoxic fragment and benchmark tool for modeling Alzheimer’s disease neurotoxicity. This article delivers workflow-driven insights, protocol refinements, and troubleshooting strategies that empower researchers to generate reproducible and mechanistically relevant data. Leverage APExBIO’s A1039 to accelerate neurodegenerative disease research with confidence.

• Guidelines for Mucocutaneous Candidiasis: Evidence and Innov

  2026-04-23

  This article reviews the 2009 Japanese guidelines for diagnosing and treating mucocutaneous candidiasis, highlighting the role of imidazole antifungals such as Neticonazole Hydrochloride. The guidelines establish best practices for clinical diagnosis, risk assessment, and topical therapy, providing a foundation for translational research and protocol optimization.

• E-64 and Lysoptosis: Redefining Cysteine Protease Inhibition

  2026-04-22

  Explore how E-64, a potent L-trans-epoxysuccinyl peptide cysteine protease inhibitor, is reshaping our understanding of regulated cell death pathways, specifically lysoptosis. This article uniquely connects molecular inhibition with the evolving biology of cell demise, grounded in recent landmark research.

• Clodronate Liposomes: Transforming Translational Macrophage

  2026-04-22

  This article provides advanced translational researchers with an integrative, evidence-based roadmap for leveraging Clodronate Liposomes in dissecting macrophage-mediated resistance in cancer immunotherapy. It contextualizes recent breakthroughs on CCL7+ tumor-associated macrophages in colorectal cancer, delivers actionable experimental strategies, and sets a new standard for product-driven scientific guidance—surpassing routine product literature to illuminate emerging opportunities in immune cell modulation.

• Applied Workflows with Enhanced ECL Chemiluminescent Detecti

  2026-04-21

  Harness the ECL Chemiluminescent Substrate Detection Kit (Enhanced) for ultra-sensitive protein detection in western blot assays, even at low-picogram levels. This guide translates cutting-edge neuroinflammation research into actionable protocols, troubleshooting, and optimization strategies for robust antibody detection and quantification.

• Elbasvir/Grazoprevir in HCV: Efficacy, Safety, and Clinical

  2026-04-21

  Wang et al. (2021) provide a detailed review of the fixed-dose combination of elbasvir and grazoprevir for hepatitis C, focusing on its pharmacological mechanisms, high efficacy against HCV genotypes 1 and 4, and favorable safety in challenging patient groups such as those with renal impairment or HIV/HCV coinfection. Their synthesis sets a benchmark for direct-acting antiviral regimens in complex clinical scenarios.

• EZ Cap Cy5 Firefly Luciferase mRNA: Precision Tracking and T

  2026-04-20

  Explore how EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) sets new standards for dual-modality mRNA tracking and translation efficiency in lipid nanoparticle (LNP) delivery systems. This article reveals unique insights into protocol design, immune modulation, and the impact of microfluidic mixer advances.

406 records 17/28 page Previous Next First page 上5页 1617181920 下5页 Last page